These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7602422)

  • 1. Identification and characterization of c-erbB-2 proteins in serum, breast tumor tissue, and SK-BR-3 cell line.
    Wu JT; Zhang P; Astill ME; Lyons BW; Wu LH
    J Clin Lab Anal; 1995; 9(3):141-50. PubMed ID: 7602422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of the intact molecule and ectodomain of C-erbB-2 oncoprotein from SK-BR-3 cells and development of immunoassays on microplate.
    Wu JT; Zhang P; Lyons BW; Wu LH
    J Clin Lab Anal; 1998; 12(5):298-303. PubMed ID: 9773962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of c-erbB-2 proteins in sera from patients with carcinomas and in breast tumor tissue cytosols: correlation with serum tumor markers and membrane-bound oncoprotein.
    Wu JT; Astill ME; Gagon SD; Bryson L
    J Clin Lab Anal; 1995; 9(3):151-65. PubMed ID: 7541455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSA immunoreactivity detected in LNCaP cell medium, breast tumor cytosol, and female serum.
    Wu JT; Zhang P; Astill ME; Wilson LW; Lyons BW; Wu LL; Stephenson R
    J Clin Lab Anal; 1995; 9(4):243-51. PubMed ID: 7562242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The extracellular domain of p185/neu is released from the surface of human breast carcinoma cells, SK-BR-3.
    Zabrecky JR; Lam T; McKenzie SJ; Carney W
    J Biol Chem; 1991 Jan; 266(3):1716-20. PubMed ID: 1671042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of c-erbB-2 gene product-related protein in culture medium conditioned by breast cancer cell line SK-BR-3.
    Alper O; Yamaguchi K; Hitomi J; Honda S; Matsushima T; Abe K
    Cell Growth Differ; 1990 Dec; 1(12):591-9. PubMed ID: 1981143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-erbB2 oncoprotein and its soluble ectodomain: a new potential tumor marker for prognosis early detection and monitoring patients undergoing Herceptin treatment.
    Wu JT
    Clin Chim Acta; 2002 Aug; 322(1-2):11-9. PubMed ID: 12104076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo effects of estrogens on c-erbB-2 oncoprotein levels in chorionic villous tissue and maternal serum.
    Mielke S; Meden H; Marx D; Wuttke W; Kuhn W
    Gynecol Endocrinol; 1997 Aug; 11(4):237-41. PubMed ID: 9272419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
    Chen CH; Lin YS; Lin CC; Yang YH; Ho YP; Tsai CC
    J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of the extracellular domain of c-erbB-2 oncoprotein in sera from patients with various carcinomas: correlation with tumor markers.
    Wu JT; Astill ME; Zhang P
    J Clin Lab Anal; 1993; 7(1):31-40. PubMed ID: 8093903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis.
    Xu FJ; Stack S; Boyer C; O'Briant K; Whitaker R; Mills GB; Yu YH; Bast RC
    Clin Cancer Res; 1997 Sep; 3(9):1629-34. PubMed ID: 9815853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ELISA for quantitation of serum C-erbB-2 oncoprotein in breast cancer patients.
    Meenakshi A; Kumar RS; Kumar NS
    J Immunoassay Immunochem; 2002; 23(3):293-305. PubMed ID: 12227416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model.
    Roetger A; Merschjann A; Dittmar T; Jackisch C; Barnekow A; Brandt B
    Am J Pathol; 1998 Dec; 153(6):1797-806. PubMed ID: 9846970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
    Tan M; Yao J; Yu D
    Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
    Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM
    Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface density of p185(c-erbB-2) determines susceptibility to anti-p185(c-erbB-2)-ricin A chain (RTA) immunotoxin therapy alone and in combination with anti-p170(EGFR)-RTA in ovarian cancer cells.
    Dean GS; Pusztai L; Xu FJ; O'Briant K; DeSombre K; Conaway M; Boyer CM; Mendelsohn J; Bast RC
    Clin Cancer Res; 1998 Oct; 4(10):2545-50. PubMed ID: 9796989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
    Ram TG; Hosick HL; Ethier SP
    J Cell Physiol; 2000 Jun; 183(3):301-13. PubMed ID: 10797304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and identification of monoclonal antibodies against c-erbB-2 p185 intracellular domain.
    Qu P; Zhang W; Cao D; Huang X; Wang H; Li M; Tian H
    Zhonghua Bing Li Xue Za Zhi; 2002 Apr; 31(2):148-50. PubMed ID: 12419164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
    Ethier SP; Langton BC; Dilts CA
    Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of c-erbB-2 oncoprotein expression in breast tissue by multiparameter flow cytometry.
    Li BD; Bauer KD; Carney WP; Duda RB
    J Surg Res; 1993 Mar; 54(3):179-88. PubMed ID: 7682635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.